ACADIA Pharmaceuticals Inc (ACAD)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$3.17B
EV to revenue ratio (TTM)
1.87
EV to ebitda
16.68
Financial Performance
Revenue (TTM)
$1.20B
Gross profit (TTM)
$0.77B
EBITDA
$0.14B
Profitability
Operating margin (TTM)
10.20%
Profit margin
30.10%
Return on assets (TTM)
4.89%
Return on equity (TTM)
31.40%
Per Share Metrics
Revenue per share (TTM)
$7.03
EPS
$2.12
Diluted EPS (TTM)
$2.12
Book value
$8.03
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
8.67
Trailing P/E
8.67
Forward P/E
20.53
PEG ratio
50.86
Price to sales ratio (TTM)
2.64
Price to book ratio (TTM)
2.28
Growth
Quarterly earnings growth (YoY)
22.80%
Quarterly revenue growth (YoY)
-26.20%
Analyst Sentiment
Strong buy
4
Buy
10
Hold
5
Sell
1
Strong sell
0
Risk & Volatility
Beta
0.89